22 devices · GMDN 54588
This category covers diagnostic kits designed to measure the level of cancer antigen 125, a protein often elevated in ovarian cancer, using a chemiluminescent immunoassay method. These tests are used clinically to help monitor disease progression or response to treatment in patients with ovarian cancer.
These devices are supplied as complete reagent kits intended for use with specific automated analyzer platforms. They are regulated as in vitro diagnostic medical devices and require appropriate regulatory clearance or approval before being marketed for clinical use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.